beta

FCSC

Fibrocell Science, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on December 28, 1995 and is headquartered in Exton, PA.

Market Cap: 29.3 Million

Primary Exchange: NASDAQ

Website: http://www.fibrocell.com

Shares Outstanding: 9.76 Million

Float: 7.43 Million

Dividend: (%)

Beta: 0.4707242100386559

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1173 trading days

From: 2015-08-05 To: 2019-12-13

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-03-13 3.0 1.0 3.0
2013-04-30 25.0 1.0 25.0
Data provided by IEX Cloud